Literature DB >> 16893522

N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis.

Mazin Magzoub1, Staffan Sandgren, Pontus Lundberg, Kamila Oglecka, Johanna Lilja, Anders Wittrup, L E Göran Eriksson, Ulo Langel, Mattias Belting, Astrid Gräslund.   

Abstract

A peptide derived from the N-terminus of the unprocessed bovine prion protein (bPrPp), incorporating the hydrophobic signal sequence (residues 1-24) and a basic domain (KKRPKP, residues 25-30), internalizes into mammalian cells, even when coupled to a sizeable cargo, and therefore functions as a cell-penetrating peptide (CPP). Confocal microscopy and co-localization studies indicate that the internalization of bPrPp is mainly through macropinocytosis, a fluid-phase endocytosis process, initiated by binding to cell-surface proteoglycans. Electron microscopy studies show internalized bPrPp-DNA-gold complexes residing in endosomal vesicles. bPrPp induces expression of a complexed luciferase-encoding DNA plasmid, demonstrating the peptide's ability to transport the cargo across the endosomal membrane and into the cytosol and nucleus. The novel CPP activity of the unprocessed N-terminal domain of PrP could be important for the retrotranslocation of partly processed PrP and for PrP trafficking inside or between cells, with implications for the infectivity associated with prion diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893522     DOI: 10.1016/j.bbrc.2006.07.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Cell penetrating peptides: how do they do it?

Authors:  Henry D Herce; Angel E Garcia
Journal:  J Biol Phys       Date:  2008-05-15       Impact factor: 1.365

2.  Human X-DING-CD4 mediates resistance to HIV-1 infection through novel paracrine-like signaling.

Authors:  Rakhee Sachdeva; Yuchang Li; Rasheda Y Shilpi; Malgorzata Simm
Journal:  FEBS J       Date:  2015-01-27       Impact factor: 5.542

3.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

4.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.

Authors:  Zhengrong Guo; Huanyan Peng; Jiwen Kang; Dianxing Sun
Journal:  Biomed Rep       Date:  2016-03-23

5.  WASH drives early recycling from macropinosomes and phagosomes to maintain surface phagocytic receptors.

Authors:  Catherine M Buckley; Navin Gopaldass; Cristina Bosmani; Simon A Johnston; Thierry Soldati; Robert H Insall; Jason S King
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

6.  The physiological regulation of macropinocytosis during Dictyostelium growth and development.

Authors:  Thomas D Williams; Robert R Kay
Journal:  J Cell Sci       Date:  2018-03-21       Impact factor: 5.285

7.  A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

Authors:  E Merit Reyes-Reyes; Yun Teng; Paula J Bates
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

8.  Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.

Authors:  Rachel J Fields; Christopher J Cheng; Elias Quijano; Caroline Weller; Nina Kristofik; Nha Duong; Christopher Hoimes; Marie E Egan; W Mark Saltzman
Journal:  J Control Release       Date:  2012-10-05       Impact factor: 9.776

9.  Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells.

Authors:  Shaoman Yin; Xingjun Fan; Shuiliang Yu; Chaoyang Li; Man-Sun Sy
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.